Intralesional hyaluronidase injection to relieve non‐hyaluronic acid filler‐induced vascular adverse events
- 2 July 2024
- journal article
- research article
- Published by Wiley in International Journal of Dermatology
- Vol. 63 (9) , 1252-1255
Abstract
Background: Vascular adverse events (VAEs) occurring during injections of soft‐tissue fillers are still considered a challenging issue for both patients and practitioners. Hyaluronidase can dissolve hyaluronic acid (HA)‐based soft‐tissue fillers during a VAE. For VAEs induced by non‐HA fillers, the absence of an “antidote” is regarded as exceptionally challenging.Methods: This multicenter study describes a case series of three VAEs induced by non‐HA fillers, for which ultrasound‐guided hyaluronidase injections were incorporated into the treatment approach.Results: Two cases of calcium hydroxylapatite and one case of poly‐L‐lactic acid‐induced VAEs are described, all of which were resolved without necrosis or scarring using a treatment approach with ultrasound‐guided hyaluronidase injections.Conclusions: Unlike the mechanical hypothesis, which assumes filler particles travel antegrade to block arterioles in a large skin area, we hypothesize vasoconstriction as the pivot in VAEs. Filler injection‐induced spasms could lead to long‐lasting vasoconstriction of the perforator arteries stemming from the central facial arteries. Our results underscore that perforasome vasoconstriction might be the leading cause of the ischemia and subsequent necrosis in VAEs and that relaxation of these perforasomes, rather than dissolving the filler material, resolves the clinical symptoms associated with VAEs.Keywords
This publication has 13 references indexed in Scilit:
- Reticulated livedoid skin patterns after soft-tissue filler–related vascular adverse eventsJournal of the American Academy of Dermatology, 2024
- Early ultrasound for diagnosis and treatment of vascular adverse events with hyaluronic acid fillersJournal of the American Academy of Dermatology, 2023
- Ultrasound-Guided Targeted vs Regional Flooding: A Comparative Study for Improving the Clinical Outcome in Soft Tissue Filler Vascular Adverse Event ManagementAesthetic Surgery Journal, 2022
- Use of hyaluronidase in plastic surgery: A reviewJournal of Plastic, Reconstructive & Aesthetic Surgery, 2021
- Intraarterial Degradation of Calcium Hydroxylapatite Using Sodium Thiosulfate – An In Vitro and Cadaveric StudyAesthetic Surgery Journal, 2021
- In Vitro Analysis of the Degradation of Calcium Hydroxylapatite Dermal Filler: A Proof-of-Concept StudyDermatologic Surgery, 2018
- The Role of Anastomotic Vessels in Controlling Tissue Viability and Defining Tissue Necrosis with Special Reference to Complications following Injection of Hyaluronic Acid FillersPlastic and Reconstructive Surgery, 2018
- New High Dose Pulsed Hyaluronidase Protocol for Hyaluronic Acid Filler Vascular Adverse EventsAesthetic Surgery Journal, 2017
- The Perforasome Theory: Vascular Anatomy and Clinical ImplicationsPlastic and Reconstructive Surgery, 2009
- Angiosome theoryBritish Journal of Plastic Surgery, 1992